(Q38255693)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25270261%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

0 references

1 reference

title

Dynamic modelling of hepatitis C virus transmission among people who inject drugs: a methodological review (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25270261%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

1 reference

1 reference

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25270261%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

author name string

V C Tran

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25270261%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

S Deuffic-Burban

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25270261%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

M Jauffret-Roustide

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25270261%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

J-S Dhersin

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25270261%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Y Yazdanpanah

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25270261%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

publication date

1 October 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25270261%20AND%20SRC:MED&resulttype=core&format=json

Journal of Viral Hepatitis

20 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25270261%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

volume

22

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25270261%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25270261%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

page(s)

213-229

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25270261%20AND%20SRC:MED&resulttype=core&format=json

Can hepatitis C virus prevalence be used as a measure of injection-related human immunodeficiency virus risk in populations of injecting drug users? An ecological analysis.

20 February 2020

cites work

1 reference

Evidence for a substantial role of sharing of injecting paraphernalia other than syringes/needles to the spread of hepatitis C among injecting drug users

21 January 2018

1 reference

Intranasal transmission of hepatitis C virus: virological and clinical evidence.

21 January 2018

1 reference

A national cross-sectional study among drug-users in France: epidemiology of HCV and highlight on practical and statistical aspects of the design

21 January 2018

1 reference

Hepatitis C virus infection in Western Europe

21 January 2018

1 reference

Supervised consumption rooms: the French Paradox

21 January 2018

1 reference

Changing of hepatitis C virus genotype patterns in France at the beginning of the third millenium: The GEMHEP GenoCII Study.

21 January 2018

1 reference

Telaprevir and peginterferon with or without ribavirin for chronic HCV infection

21 January 2018

1 reference

Efficacy of boceprevir, an NS3 protease inhibitor, in combination with peginterferon alfa-2b and ribavirin in treatment-naive patients with genotype 1 hepatitis C infection (SPRINT-1): an open-label, randomised, multicentre phase 2 trial

21 January 2018

1 reference

Telaprevir with peginterferon and ribavirin for chronic HCV genotype 1 infection

21 January 2018

1 reference

Boceprevir for untreated chronic HCV genotype 1 infection

21 January 2018

1 reference

Response-guided telaprevir combination treatment for hepatitis C virus infection

21 January 2018

1 reference

Chronic hepatitis C: treatments of the future

21 January 2018

1 reference

Sofosbuvir and ledipasvir fixed-dose combination with and without ribavirin in treatment-naive and previously treated patients with genotype 1 hepatitis C virus infection (LONESTAR): an open-label, randomised, phase 2 trial

21 January 2018

1 reference

Risk factors for hepatitis C virus transmission to health care workers after occupational exposure: a European case-control study

21 January 2018

1 reference

Optimal control of hepatitis C antiviral treatment programme delivery for prevention amongst a population of injecting drug users

21 January 2018

1 reference

Mathematical modelling of hepatitis C treatment for injecting drug users

21 January 2018

1 reference

Cost-effectiveness of hepatitis C virus antiviral treatment for injection drug user populations

21 January 2018

1 reference

Modelling the impact on Hepatitis C transmission of reducing syringe sharing: London case study.

21 January 2018

1 reference

Can needle and syringe programmes and opiate substitution therapy achieve substantial reductions in hepatitis C virus prevalence? Model projections for different epidemic settings

21 January 2018

1 reference

Understanding the trends in HIV and hepatitis C prevalence amongst injecting drug users in different settings--implications for intervention impact

21 January 2018

1 reference

Modelling the transmission of HIV and HCV among injecting drug users in Rawalpindi, a low HCV prevalence setting in Pakistan

21 January 2018

1 reference

Treatment of hepatitis C as prevention: a modeling case study in Vietnam

21 January 2018

1 reference

Optimal targeting of Hepatitis C virus treatment among injecting drug users to those not enrolled in methadone maintenance programs

21 January 2018

1 reference

A nested-epidemic model for the spread of hepatitis C among injecting drug users.

21 January 2018

1 reference

Potential impact of vaccination on the hepatitis C virus epidemic in injection drug users

21 January 2018

1 reference

The impact of behavioural changes on the prevalence of human immunodeficiency virus and hepatitis C among injecting drug users

21 January 2018

1 reference

Modelling antiviral treatment to prevent hepatitis C infection among people who inject drugs in Victoria, Australia

21 January 2018

1 reference

Mathematically modelling the spread of hepatitis C in injecting drug users

21 January 2018

1 reference

A time since onset of injection model for hepatitis C spread amongst injecting drug users

21 January 2018

1 reference

Ignoring 'downstream infection' in the evaluation of harm reduction interventions for injection drug users.

21 January 2018

1 reference

The efficiency of targeted intervention in limiting the spread of HIV and Hepatitis C Virus among injecting drug users

21 January 2018

1 reference

Decline in incidence of HIV and hepatitis C virus infection among injecting drug users in Amsterdam; evidence for harm reduction?

21 January 2018

1 reference

Determinants of persistent spread of HIV in HCV-infected populations of injecting drug users

21 January 2018

1 reference

Hepatitis C virus treatment for prevention among people who inject drugs: Modeling treatment scale-up in the age of direct-acting antivirals

21 January 2018

1 reference

A mathematical model for HIV and hepatitis C co-infection and its assessment from a statistical perspective

21 January 2018

1 reference

Is the HCV-HIV co-infection prevalence amongst injecting drug users a marker for the level of sexual and injection related HIV transmission?

21 January 2018

1 reference

Modelling the prevalence of HCV amongst people who inject drugs: an investigation into the risks associated with injecting paraphernalia sharing

21 January 2018

1 reference

Cost-effectiveness of HCV case-finding for people who inject drugs via dried blood spot testing in specialist addiction services and prisons

21 January 2018

1 reference

Combination interventions to prevent HCV transmission among people who inject drugs: modeling the impact of antiviral treatment, needle and syringe programs, and opiate substitution therapy

21 January 2018

1 reference

Model for hepatitis C virus transmissions

21 January 2018

1 reference

Hepatitis C transmission and treatment in contact networks of people who inject drugs

21 January 2018

1 reference

A computer model of the spread of hepatitis C virus among injecting drug users

21 January 2018

1 reference

Cost effectiveness of screening strategies for early identification of HIV and HCV infection in injection drug users

21 January 2018

1 reference

The cost-effectiveness of Vancouver's supervised injection facility

21 January 2018

1 reference

Dynamic population epidemic models

21 January 2018

1 reference

A Contribution to the Mathematical Theory of Epidemics

21 January 2018

1 reference

Modelling the force of infection for hepatitis B and hepatitis C in injecting drug users in England and Wales

21 January 2018

1 reference

Protection against persistence of hepatitis C.

21 January 2018

1 reference

Demographic, risk behaviour and personal network variables associated with prevalent hepatitis C, hepatitis B, and HIV infection in injection drug users in Winnipeg, Canada

21 January 2018

1 reference

Hepatitis C virus infection and injection drug users: prevention, risk factors, and treatment

21 January 2018

1 reference

Female sex and IL28B, a synergism for spontaneous viral clearance in hepatitis C virus (HCV) seroconverters from a community-based cohort

21 January 2018

1 reference

Influence of human immunodeficiency virus infection on the course of hepatitis C virus infection: a meta-analysis

21 January 2018

1 reference

Estimating the variability in the risk of infection for hepatitis C in the Glasgow injecting drug user population

21 January 2018

1 reference

Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance

21 January 2018

1 reference

Social structural and behavioral underpinnings of hyperendemic hepatitis C virus transmission in drug injectors

21 January 2018

1 reference

Hepatitis C virus phylogenetic clustering is associated with the social-injecting network in a cohort of people who inject drugs

21 January 2018

1 reference

Agent-based modeling: methods and techniques for simulating human systems

21 January 2018

1 reference

A general method for numerically simulating the stochastic time evolution of coupled chemical reactions

21 January 2018

1 reference

The Structure and Function of Complex Networks

21 January 2018

1 reference

A critical point for random graphs with a given degree sequence

21 January 2018

1 reference

The effect of household distribution on transmission and control of highly infectious diseases.

21 January 2018

1 reference

Stochastic blockmodels: First steps

21 January 2018

1 reference

Susceptible-infected-recovered epidemics in dynamic contact networks.

21 January 2018

1 reference

The effect of pair formation and variable infectivity on the spread of an infection without recovery.

21 January 2018

1 reference

HIV transmissions by stage in dynamic sexual partnerships

21 January 2018

1 reference

The dual impact of antiretroviral therapy and sexual behaviour changes on HIV epidemiologic trends in Uganda: a modelling study

21 January 2018

1 reference

New challenges for mathematical and statistical modeling of HIV and hepatitis C virus in injecting drug users

21 January 2018

1 reference

Can antiviral therapy for hepatitis C reduce the prevalence of HCV among injecting drug user populations? A modeling analysis of its prevention utility

21 January 2018

1 reference

Modelling a disease-relevant contact network of people who inject drugs

21 January 2018

1 reference